Difference between revisions of "Team:NCTU Formosatest"

(Created page with "{{Team:NCTU_Formosa/navigation}} <html> <head> <link href="https://2015.igem.org/Team:NCTU_Formosa/wiki_reset?action=raw&ctype=text/css" rel="stylesheet"> <script src="https://...")
 
Line 43: Line 43:
 
         position:absolute;
 
         position:absolute;
 
         left:8%;
 
         left:8%;
−
height:100%;
+
 
top:0vh;
 
top:0vh;
 
         margin-left:0;  
 
         margin-left:0;  
Line 50: Line 50:
 
         background:#fff;
 
         background:#fff;
 
         width:28%;
 
         width:28%;
−
height:100%;
+
 
position:absolute;
 
position:absolute;
 
         left:36%;
 
         left:36%;
Line 59: Line 59:
 
         background:#fff;
 
         background:#fff;
 
         width:28%;
 
         width:28%;
−
height:100%;
+
 
position:absolute;
 
position:absolute;
 
         left:64%;
 
         left:64%;

Revision as of 13:24, 18 September 2015

The only thing we can detect is everything.

Who are we

NCTU_Formosa created an organization-APOllO, which stands for Almighty Probe of scFv Organization. APOllO devoted to developing detection technology by utilizing antibodies. In 2015, We cooperated with iGEM with Synthetic Biology to develop a brand new detection platform.

What's new

APOllO E.Cotector:
Our organization create a customized scFv detection platform by co-transforming any desired plasmid. ScFv utilizing antigen-antibody interaction can act as probes. Our E.Cotector can therefore have the function of a detector.

What do we care

In 2015, we focus on helping doctors select the appropriate candidates for monoclonal-antibody targeted drug for patient's treatment in a more inexpensive way. If the cost for diagnosis decreases, more patients can afford it. Therefore, more patients can be prescribed and treated, lowering the mortality rate of cancer.